Lab901 and Biofortuna to collaborate on automated PCR Dx for HLA-related diseases
Laboratory automation firm Lab901 is to collaborate with molecular diagnostics specialist Biofortuna of Liverpool, UK on the launch of an automated PCR Dx system for the rapid detection of certain HLA-related diseases, such as Coeliac disease.
Laboratory automation firm Lab901 is to collaborate with molecular diagnostics specialist Biofortuna of Liverpool, UK on the launch of an automated PCR Dx system for the rapid detection of certain HLA-related diseases, such as Coeliac disease.
The Edinburgh firm will use its automated ScreenTape PCR analysis with Biofortuna's multiplex PCR diagnostics kits for the detection of Coeliac disease, reactive arthritis, diabetes and drug hypersensitivity.
Lab901's automated ScreenTape PCR includes an instrument, pre-packed consumables and analysis software that automatically interprets results, simplifying and speeding up gel electrophoresis.
"We feel the addition of new content from Biofortuna will help both companies grow sales rapidly," said Richard Rowling, Lab901's sales and marketing director.
Financial terms were not disclosed.